featured
Infections in Patients With Moderate to Severe Psoriasis Treated With Ixekizumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The British Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Infections From 7 Clinical Trials of Ixekizumab, an Anti-Interleukin-17A Monoclonal Antibody, in Patients With Moderate-to-Severe Psoriasis
Br J Dermatol 2017 Jun 10;[EPub Ahead of Print], KA Papp, H Bachelez, A Blauvelt, KL Winthrop, R Romiti, M Ohtsuki, N Acharya, DK Braun, L Mallbris, F Zhao, W Xu, CD Walls, B StroberFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.